| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Ordinary Shares | 204K | $1.4M | $6.84 | 01 Jul 2025 | Direct |
| Structure Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Employee Stock Option (right to buy) | 196K | 15 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GPCR | Structure Therapeutics Inc. | 01 Jul 2025 | 1 | -$87.8K | 4 | CHIEF SCIENTIFIC OFFICER | 20 Aug 2025, 17:00 |
| GPCR | Structure Therapeutics Inc. | 15 Mar 2025 | 2 | $0 | 4 | CHIEF SCIENTIFIC OFFICER | 18 Mar 2025, 20:45 |
| GPCR | Structure Therapeutics Inc. | 01 Mar 2025 | 2 | -$51K | 4 | CHIEF SCIENTIFIC OFFICER | 03 Jul 2025, 17:15 |
| GPCR | Structure Therapeutics Inc. | 03 Jun 2024 | 6 | -$1.65M | 4 | CHIEF SCIENTIFIC OFFICER | 05 Jun 2024, 19:38 |
| GPCR | Structure Therapeutics Inc. | 15 Mar 2024 | 1 | $0 | 4/A | CHIEF SCIENTIFIC OFFICER | 20 Mar 2024, 19:42 |
| GPCR | Structure Therapeutics Inc. | 15 Mar 2024 | 2 | $0 | 4 | CHIEF SCIENTIFIC OFFICER | 19 Mar 2024, 16:51 |
| GPCR | Structure Therapeutics Inc. | 02 Feb 2023 | 0 | $0 | 3 | Chief Scientific Officer | 02 Feb 2023, 17:12 |